Is Akorn Inc (NASDAQ:AKRX) a Buy? The Stock Reported more Sellers

June 17, 2018 - By Marry Poplack

The stock of Akorn Inc (NASDAQ:AKRX) registered an increase of 29.8% in short interest. AKRX’s total short interest was 12.58M shares in June as published by FINRA. Its up 29.8% from 9.69M shares, reported previously. With 4.08M shares average volume, it will take short sellers 3 days to cover their AKRX’s short positions. The short interest to Akorn Inc’s float is 13.48%.

The stock increased 2.53% or $0.38 during the last trading session, reaching $15.42. About 1.98M shares traded. Akorn, Inc. (NASDAQ:AKRX) has declined 57.67% since June 17, 2017 and is downtrending. It has underperformed by 70.24% the S&P500.

Akorn, Inc., a specialty generic pharmaceutical company, develops, makes, and markets specialized generic and branded pharmaceuticals, over-the-counter drug products, and animal health products in the United States and internationally. The company has market cap of $1.93 billion. The firm operates in two divisions, Prescription Pharmaceuticals and Consumer Health. It currently has negative earnings. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics.

Akorn, Inc. (NASDAQ:AKRX) Ratings Coverage

Among 6 analysts covering Akorn (NASDAQ:AKRX), 0 have Buy rating, 0 Sell and 6 Hold. Therefore 0 are positive. Akorn had 6 analyst reports since February 22, 2018 according to SRatingsIntel. The stock of Akorn, Inc. (NASDAQ:AKRX) has “Hold” rating given on Thursday, March 29 by RBC Capital Markets. The stock of Akorn, Inc. (NASDAQ:AKRX) earned “Hold” rating by William Blair on Wednesday, February 28. The rating was maintained by Susquehanna with “Hold” on Thursday, March 15. On Monday, April 23 the stock rating was maintained by Piper Jaffray with “Hold”. Craig Hallum maintained the stock with “Hold” rating in Monday, April 23 report.

Another recent and important Akorn, Inc. (NASDAQ:AKRX) news was published by which published an article titled: “Akorn And Fresenius: Merger Arbitrage” on June 08, 2018.

Akorn, Inc. (NASDAQ:AKRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: